This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Topic Collections  • Prognosis/ Outcomes  • Neoplasms  • Alert me on articles by topic

Wenyuan Liu, MBChB, MD; Grant A. McArthur, MBBS, PhD; Melanie Trivett, PhD; William K. Murray, MBBS; Rory Wolfe, BSc, PhD; John W. Kelly, MBBS, MD

Arch Dermatol. 2008;144(4):555-556.

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

Previous studies, using patient recall, have suggested that melanoma growth rate may be an independent prognostic marker¹ and that rapid growth tends to occur in older men and have nodular morphologic characteristics and a different clinical presentation from other melanomas.²

Retrospective recall of time delay leading up to melanoma diagnosis is regarded by some as unreliable.³ However, there is no other practical method by which to evaluate the evolution of a melanoma from the outset. In a previous study,² the ratio between Breslow thickness and time interval for a melanoma to develop was used as an estimate for melanoma rate of growth (ROG). This subjective measure of ROG based on patient recall correlated significantly with mitotic rate, an objective measure of melanoma proliferation, indicating the . . . [Full Text of this Article]

Methods


Results

Comment

AUTHOR INFORMATION